@article{2997015,
    title = "COVID-19 and ischemic stroke",
    author = "Sagris, D. and Papanikolaou, A. and Kvernland, A. and Korompoki, E. and Frontera, J.A. and Troxel, A.B. and Gavriatopoulou, M. and Milionis, H. and Lip, G.Y.H. and Michel, P. and Yaghi, S. and Ntaios, G.",
    journal = "European Journal of Paediatric Neurology",
    year = "2021",
    volume = "28",
    number = "11",
    pages = "3826-3836",
    publisher = "John Wiley and Sons Inc",
    issn = "1090-3798",
    doi = "10.1111/ene.15008",
    keywords = "coronavirus disease 2019;  global health;  heart disease;  human;  incidence;  intensive care unit;  ischemic stroke;  Medline;  pathophysiology;  practice guideline;  prevalence;  Review;  Scopus;  signal transduction;  thrombosis;  brain ischemia;  cerebrovascular accident;  complication;  pandemic, Brain Ischemia;  COVID-19;  Humans;  Ischemic Stroke;  Pandemics;  SARS-CoV-2;  Stroke",
    abstract = "Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment of stroke in the setting of COVID-19 particularly challenging. In this review, we summarize the current knowledge on epidemiology, clinical manifestation, and pathophysiology of ischemic stroke in patients with COVID-19 to bridge the gap from bench to bedside and clinical practice during the most challenging global health crisis of the last decades. © 2021 European Academy of Neurology"
}